Heat-stable carbetocin has been added to the WHO Essential Medicines List for the prevention of excessive bleeding after childbirth
Ferring announces changes to Executive Committee
Ferring collaboration with digital health innovators WOOM aims to help more people build families faster
Ferring statement on subsidised pricing of heat-stable carbetocin for the prevention of postpartum haemorrhage in low- and lower-middle income countries
Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments
Ferring International Center S.A.Ch. de la Vergognausaz 50CH-1162 Saint-PrexSwitzerlandTel: +41 58 301 00 00Fax: +41 58 301 00 10
Email for media enquiries only.For other queries, please see our Contact page.
FERRING INTERNATIONAL CENTER S.A.CH. DE LA VERGOGNAUSAZ 50 1162 SAINT-PREXSWITZERLAND
TEL: +41 58 301 00 00FAX: +41 58 301 00 10
This global corporate website provides general information about the global Ferring Group. For information about Ferring or its products in a specific country, please select your country in the Global Locator. FERRING, the FERRING PHARMACEUTICALS logo and other Ferring product trade names are trademarks of Ferring B.V. save where indicated otherwise. ©2018 Ferring B.V.